Guardiola, J M <br/><br/>
Switching HIV-1 protease inhibitor therapy: which? When? And why?  [electronic resource] 

 -  Archives of internal medicine  Jan 1999 
 - 194-5 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>0003-9926 
<br/><br/><label>Standard No.: </label>10.1001/archinte.159.2.194  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS-Related Opportunistic Infections--mortality<br/>Acquired Immunodeficiency Syndrome--complications<br/>Anti-HIV Agents--administration & dosage<br/>Drug Administration Schedule<br/>HIV Protease Inhibitors--administration & dosage<br/>Humans<br/>Indinavir--administration & dosage<br/>Odds Ratio<br/>Ritonavir--administration & dosage<br/>Saquinavir--administration & dosage<br/>Spain<br/>Survival Analysis<br/>Treatment Failure<br/>Treatment Outcome